Compare IDEXX Laboratories, Inc. (IDXX) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Spotify Technology — how do they compare? IDEXX Laboratories, Inc. trades at $558.04 (market cap $44.48B), while Spotify Technology trades at $490 (market cap $101.23B). The key difference: Spotify Technology is far larger — about 2.3× IDEXX Laboratories, Inc.'s market cap. Which is the better fit depends on your goals.
| IDXX | SPOT | |
|---|---|---|
Market Cap | $44.48B | $101.23B |
Sector | Health | Media |
52-Week High | $766.68 | $738.53 |
52-Week Low | $520.87 | $412.75 |
Enterprise Value | $45.38B | $91.81B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Spotify (SPOT) trades at $493.49, up 3.21% today, showing strong momentum after recent earnings beats. The stock faces technical resistance near $498 with bearish moving average signals. Fundamentally, the company demonstrates impressive growth with revenue reaching $17.19B in 2025 and net income surging to $2.21B, representing a 12.87% margin. Recent AI integration initiatives and expanded family account features highlight ongoing innovation.
Wall Street maintains a bullish stance with 61.5% buy ratings and a $617 consensus target, representing 25% upside potential. However, elevated valuation multiples (P/E 32.6, P/S 5.0) and competitive pressures from streaming rivals present near-term risks. The Q2 2026 earnings report will be crucial for validating the current growth trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
